Obese patients are at risk for the development of cardiovascular diseases, which can in part
be explained by disturbances in the haemostatic and fibrinolytic systems. Indeed, obese …

The development of thrombotic disorders in humans is one of the most common causes of
morbidity and mortality in the Western world. Thrombotic disease can be classified in broad …

Background—It is pathophysiologically conceivable that genetic variations in coagulation
and fibrinolytic proteins are associated with the risk of myocardial infarction. Methods and …

High plasminogen activator inhibitor 1 (PAI‐1) levels are associated with an increased
cardiovascular risk of atherothrombosis. Furthermore, increased plasma PAI‐1 levels are …

Dissolution of the fibrin blood clot is regulated in large part by plasminogen activator
inhibitor-1 (PAI-1). Elevated levels of plasma PAI-1 may be an important risk factor for …

A number of prospective epidemiologic studies have now tested the hypothesis that plasma
measures of hemostatic factors measured in initially healthy subjects may predict the future …

Although the common 4G/5G polymorphism in the promoter of the PAI‐1 gene was
suggested to be a risk factor for some of the thrombotic disorders, its significance in the …

The pathogenesis of arterial thrombotic disease involves multiple genetic and environmental
factors related to atherosclerosis and thrombosis. Acute thrombosis at the site of a ruptured …

The specific aim of the current study of 133 women with at least 1 pregnancy and measures
of hypofibrinolytic and thrombophilic gene mutations was to determine retrospectively …

In the mobile era, more and more financial institutions are beginning to cooperate with
financial technology companies to enhance services and attract customers. The emergence …